Colgate-Palmolive (NYSE:CL – Get Free Report) will likely be issuing its Q4 2025 results before the market opens on Friday, January 30th. Analysts expect the company to announce earnings of $0.92 per share and revenue of $5.1288 billion for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, January 30, 2026 at 8:30 AM ET.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.91 earnings per share. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Colgate-Palmolive Trading Up 0.8%
Shares of CL opened at $85.86 on Wednesday. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.60 and a current ratio of 0.93. The company has a market capitalization of $69.21 billion, a PE ratio of 24.05, a price-to-earnings-growth ratio of 5.75 and a beta of 0.30. The stock has a fifty day moving average of $80.32 and a two-hundred day moving average of $81.37. Colgate-Palmolive has a fifty-two week low of $74.54 and a fifty-two week high of $100.18.
Colgate-Palmolive Dividend Announcement
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of CL. Brighton Jones LLC boosted its holdings in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP increased its position in Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after purchasing an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. lifted its holdings in shares of Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after buying an additional 245 shares during the last quarter. Nebula Research & Development LLC increased its holdings in Colgate-Palmolive by 165.5% in the second quarter. Nebula Research & Development LLC now owns 10,326 shares of the company’s stock worth $939,000 after buying an additional 6,437 shares during the last quarter. Finally, Sei Investments Co. raised its position in Colgate-Palmolive by 21.7% during the second quarter. Sei Investments Co. now owns 657,093 shares of the company’s stock valued at $59,732,000 after acquiring an additional 116,968 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
Several brokerages recently weighed in on CL. Wells Fargo & Company set a $86.00 target price on Colgate-Palmolive and gave the stock an “equal weight” rating in a research report on Tuesday, January 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. UBS Group increased their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research report on Wednesday, January 14th. Piper Sandler set a $88.00 price target on Colgate-Palmolive and gave the company an “overweight” rating in a report on Tuesday, January 6th. Finally, Barclays set a $83.00 price objective on shares of Colgate-Palmolive in a research note on Friday, January 16th. Eleven analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.44.
View Our Latest Stock Analysis on CL
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy This Stock at 9:30 AM on MONDAY!
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
